Skip to Content

Nanomedicine

Gentler tumor treatment

Oct 10, 2021 | ANDREA SIX

Radiation therapy is one of the cornerstones of cancer therapy. However, some types of tumor respond little or hardly at all to radiation. If it were possible to make tumor cells more sensitive, treatment would be more effective and gentler. Empa researchers have now succeeded in using metal oxide nanoparticles as "radiosensitizers" – and in producing them on an industrial scale.

/documents/56164/18238992/EQ73-Metalloxid-Teaser.jpg/4b276f7c-b4f7-413f-8885-3a97c6cfc796?t=1632473640373
Fire and Ice: Empa researcher Lukas Gerken produces nanoparticles for cancer therapy using flame synthesis. To make the tiny metal particles visible, the electron microscope is cooled to freezing temperatures with liquid nitrogen. Image: Empa

Today, various treatment methods are available for cancer that can complement each other. Radiation therapy is frequently used, and can be combined with surgery and chemotherapy, for example. Although treatment with ionizing radiation has been used in medicine for more than 100 years, even modern oncology is sometimes not satisfied with its effectiveness. The reason: Malignant tumors are not always sensitive enough to radiation. "If the sensitivity of the tumor cells could be increased, radiotherapy could be carried out more effectively and more gently," says Empa researcher Lukas Gerken.

In other words: A desired treatment outcome could be achieved with a lower dose of radiation than is currently the case, or particularly radiation-resistant tumors could finally become sensitive to radiation. The team led by Lukas Gerken and Inge Herrmann from the "Particles-Biology Interactions Laboratory" at Empa in St. Gallen and the "Nanoparticle Systems Engineering Laboratory" at ETH Zurich is therefore working with oncologists at the Cantonal Hospital in St. Gallen to find ways to sensitize tumor cells to radiation.

The researchers have set their sights on nanoparticles made of metal oxides that can act as so-called radiosensitizers. The team has now succeeded in producing these radiosensitizers in large quantities and analyzing their effect in more detail. The researchers recently published their results in the journal Chemistry of Materials.

Cured in the fire
/documents/56164/18238992/EQ73-Metalloxid-para-Hafnium.jpg/3a93c868-d253-4411-bb2d-ee986141da29?t=1632473639057
Tiny metallic particles: Hafnium dioxide nanoparticles produced by flame synthesis are only about 7 nanometers in size. Image: Empa / ACS Chemistry of Materials

In cancer research, studies are currently underway with various classes of substances to make the irradiation of tumors more effective. Exactly how nanoparticles made of gold or more exotic metal oxides such as hafnium dioxide work in this context is not yet fully understood. What is known, though, is that a complex reaction cascade exerts oxidative stress in cancer cells. In this way, the repair mechanisms of the malignant cells may be overwhelmed.

In order for the nanoparticles to be made available for clinical use, two hurdles had to be overcome: Production via conventional wet chemistry methods makes it difficult to produce quantities on an industrial scale, and there is a lack of comparative analyses on the efficacy of different substances.

Empa researcher Gerken has now succeeded in producing metal oxide radiosensitizers using a method that is ideally suited to industrial applications: He relied on flame synthesis to obtain top-quality oxides of hafnium, zirconium and titanium. "Thanks to this production method, it is even possible – depending on the production facility – to synthesize several kilograms per day," explains Gerken. For the laboratory analyses at Empa, however, the scientist made do with just a few grams.

Shiny little helpers

The chemical element hafnium is named after the place it was discovered, Copenhagen (Hafnia in Latin). The chemist and Nobel Prize winner George de Hevesy and the physicist Dirk Coster were finally able to detect the element from the titanium group in 1923 by means of X-ray spectroscopy, after various scientists such as Nobel Prize winner Niels Bohr had long suspected its existence. Hafnium does not normally occur in the human body and is non-toxic. In oncology, it is hoped that hafnium will have a supporting effect in the treatment of cancer. First clinical trials have already been completed. 

Inside the cell: Nanoparticles of hafnium dioxide (yellow-green) accumulate in cancer cells and can cause cell damage after irradiation. (Electron microscopy, colored) Image: Empa/ ETH Zurich

Better than gold
/documents/56164/18238992/EQ73+Metall+Lukas+para/7be519fd-5efe-444b-938f-74f786a5f900?t=1633088095827
Confident: Lukas Gerken wants to advance the clinical application of metal oxide nanoparticles in radiotherapy. Image: Empa

Once the nanoparticles were available in suitable quantities, Lukas Gerken was able to screen the "gems" in detail, for example using X-ray spectroscopy and electron microscopy. His verdict: "We can produce sterile, high-quality metal oxide nanoparticles that appear harmless to healthy cells," the researcher explains. He proved this using cell cultures that he treated with different nanoparticle suspensions in the lab. The metal oxides accumulated in large quantities inside the cells. The front-runner was hafnium dioxide: Here, half a billion nanoparticles entered each individual cell without being toxic. Compared to the metal oxides, nanogold did much worse with the same particle size: About 10 to 30 times fewer gold particles made it into the cell.

As harmless as the substances initially are to healthy cells, they unfold their effects powerfully when used in radiation. The team was able to demonstrate this using cancer cell lines. If the cell cultures were treated with metal oxides and then bombarded with X-rays, the killing effect increased significantly. Hafnium dioxide turned out to be the most potent tool: Tumor cells treated with hafnium particles could be eliminated with less than half the radiation dose. This first comparative study also showed that hafnium dioxide is even four times more effective than nanogold and titanium dioxide. Healthy human cells (so-called fibroblasts), on the other hand, showed no negative radiation effects after nanoparticle treatment.

The results make Lukas Gerken confident: "We will continue on this path to explore the nanoparticles' mechanism of action and further optimize their efficiency." He hopes that his studies will thus advance the clinical application of nanoparticles in radiation therapy.

Further information

Lukas Gerken
Particles-Biology Interactions
Phone +41 58 765 7387

Editor / Media contact

Dr. Andrea Six
Communication
Phone +41 58 765 61 33

Infrared technology

Seeing the world through different eyes

Short-wave infrared light (SWIR) is useful for many things: It helps sort out damaged fruit and inspecting silicon chips, and it enables night vision devices with sharp images. But SWIR cameras have so far been based on expensive electronics. Researchers at Empa, EPFL, ETH Zurich and the University of Siena have now developed a SWIR screen consisting of just eight thin layers on a glass surface. This could make IR cameras useful everyday objects.
>>>>
Environmental Pollution

Poison source in the idyll

Sediments in the Spöl, a small river in the very south of the canton Graubünden, are contaminated with PCBs. The chemicals originate from a 50-year-old anti-corrosion coating of a hydroelectric power plant in an upstream dam; they are transported and distributed with the waters of the Spöl – all the way to the Black Sea. Now the river has to be remediated. What is disputed, though, is the extent to which this must be done – and who will pay for it. Analyses by Empa scientists play a central role in this: They show just how much PCB is hidden in which areas of the riverbed.
>>>>
Energy

Heat storage in the deep

In Dübendorf, Empa is currently building a new, future-oriented research campus, co-operate, where groundbreaking research is conducted – and which is itself an object of research.
>>>>

Quick Access

The latest EmpaQuarterly:
Focus: Energy revolution